ArticleNeurology and therapy2026

Comparative Efficacy of Rozanolixizumab with Efgartigimod or Intravenous Immunoglobulin in Generalized Myasthenia Gravis Using Matching Adjusted Indirect Comparisons.

Vikalp Maheshwari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.